b-AP15 enhances TRAIL-induced cell death in HNSCC via the induction of ROS/JNK/DR5 signalling

Fin T A Brown, Lucy Quesne, Louisa M Wootton, Holly Foxell, Ipek Erseven, Emilia Ewen Benns, Molly Tate, Ethan L Morgan · 2026

Read b-AP15 enhances TRAIL-induced cell death in HNSCC via the induction of ROS/JNK/DR5 signalling by Fin T A Brown, Lucy Quesne, Louisa M Wootton, Holly Foxell, Ipek Erseven, Emilia Ewen Benns, Molly Tate, Ethan L Morgan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13364667.txt.

Description

Fin Brown and co-authors test a drug pairing against head and neck cancer cells in a 2026 study. These cancers often resist chemo and radiation, and a survival pathway helps the cells hold out. The drug b-AP15 blocks part of that pathway and can kill such cells on its own. The team asked whether it also makes cells weak to TRAIL, a signal that tells cancer cells to die.

Lab tests said yes. The drug raised levels of a TRAIL receptor called DR5 on the cells. That rise needed stress signals inside the cell, namely reactive oxygen species and the JNK pathway. Blocking a survival gene also played a role. Pairing the drug with a second class of blockers killed even more cells. The authors call for animal studies next.

Catalog record

CREATORFin T A Brown, Lucy Quesne, Louisa M Wootton, Holly Foxell, Ipek Erseven, Emilia Ewen Benns, Molly Tate, Ethan L Morgan
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13364667

Browse the full library · About the Tower of Babel